• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素酶在肠道来源的脂蛋白在肝脏摄取和小鼠脂肪条纹形成中的作用。

Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.

机构信息

Department of Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel.

出版信息

PLoS One. 2011 Apr 4;6(4):e18370. doi: 10.1371/journal.pone.0018370.

DOI:10.1371/journal.pone.0018370
PMID:21483695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3070732/
Abstract

BACKGROUND

Heparanase modulates the level of heparan sulfate proteoglycans (HSPGs) which have an important role in multiple cellular processes. Recent studies indicate that HSPGs have an important function in hepatic lipoprotein handling and processes involving removal of lipoprotein particles.

PRINCIPAL FINDINGS

To determine the effects of decreased HSPGs chain length on lipoprotein metabolism and atherosclerosis, transgenic mice over-expressing the human heparanase gene were studied. Hepatic lipid uptake in hpa-Tg mice were evaluated by giving transgenic mice oral fat loads and labeled retinol. Sections of aorta from mice over-expressing heparanase (hpa-Tg) and controls (C57/BL6) fed an atherogenic diet were examined for evidence of atherosclerosis. Heparanase over-expression results in reduced hepatic clearance of postprandial lipoproteins and higher levels of fasting and postprandial serum triglycerides. Heparanase over-expression also induces formation of fatty streaks in the aorta. The mean lesion cross-sectional area in heparanase over-expressing mice was almost 6 times higher when compared to control mice (23,984 µm(2)±5,922 vs. 4,189 µm(2)±1,130, p<0.001).

CONCLUSIONS

Over-expression of heparanase demonstrates the importance of HSPGs for the uptake of intestinal derived lipoproteins and its role in the formation of fatty streaks.

摘要

背景

肝素酶调节硫酸乙酰肝素蛋白聚糖(HSPGs)的水平,HSPGs 在多种细胞过程中具有重要作用。最近的研究表明,HSPGs 在肝脏脂蛋白处理和涉及脂蛋白颗粒清除的过程中具有重要功能。

主要发现

为了确定 HSPGs 链长降低对脂蛋白代谢和动脉粥样硬化的影响,研究了过度表达人肝素酶基因的转基因小鼠。通过给予转基因小鼠口服脂肪负荷和标记视黄醇,评估 hpa-Tg 小鼠的肝脂质摄取。用动脉粥样硬化饮食喂养过度表达肝素酶(hpa-Tg)和对照(C57/BL6)的小鼠的主动脉切片检查动脉粥样硬化的证据。肝素酶过表达导致餐后脂蛋白在肝脏中的清除减少,空腹和餐后血清甘油三酯水平升高。肝素酶过表达还诱导主动脉中形成脂肪条纹。与对照小鼠相比,肝素酶过表达小鼠的平均病变截面积几乎高 6 倍(23984µm²±5922 与 4189µm²±1130,p<0.001)。

结论

肝素酶的过表达证明了 HSPGs 对肠道衍生脂蛋白摄取的重要性及其在形成脂肪条纹中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/2df0378ee459/pone.0018370.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/612faeb606ff/pone.0018370.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/bf1254de6912/pone.0018370.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/70e86832d414/pone.0018370.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/4bd0a302cedb/pone.0018370.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/2df0378ee459/pone.0018370.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/612faeb606ff/pone.0018370.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/bf1254de6912/pone.0018370.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/70e86832d414/pone.0018370.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/4bd0a302cedb/pone.0018370.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e16/3070732/2df0378ee459/pone.0018370.g005.jpg

相似文献

1
Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.肝素酶在肠道来源的脂蛋白在肝脏摄取和小鼠脂肪条纹形成中的作用。
PLoS One. 2011 Apr 4;6(4):e18370. doi: 10.1371/journal.pone.0018370.
2
Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E mice.肝素酶抑制可减轻 E 小鼠动脉粥样硬化进展和肝脏脂肪变性。
Atherosclerosis. 2018 Sep;276:155-162. doi: 10.1016/j.atherosclerosis.2018.07.026. Epub 2018 Jul 24.
3
Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.乙酰肝素酶在成骨细胞中表达,并刺激骨形成和骨量增加。
J Cell Physiol. 2006 Jun;207(3):784-92. doi: 10.1002/jcp.20625.
4
Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.炎症细胞因子和脂肪酸调节内皮细胞乙酰肝素酶的表达。
Biochemistry. 2004 May 4;43(17):4971-7. doi: 10.1021/bi0356552.
5
Involvement of heparanase in atherosclerosis and other vessel wall pathologies.乙酰肝素酶在动脉粥样硬化和其他血管壁病变中的作用。
Matrix Biol. 2013 Jun 24;32(5):241-51. doi: 10.1016/j.matbio.2013.03.002. Epub 2013 Mar 13.
6
Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.哺乳动物乙酰肝素酶的转基因表达揭示了硫酸乙酰肝素在组织形态发生、血管生成和摄食行为中的生理功能。
FASEB J. 2004 Feb;18(2):252-63. doi: 10.1096/fj.03-0572com.
7
Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.内皮细胞衍生的脂蛋白脂肪酶与餐后富含甘油三酯的脂蛋白结合,并在体内介导其肝脏清除。
J Mol Med (Berl). 2002 Sep;80(9):576-84. doi: 10.1007/s00109-002-0351-5. Epub 2002 Jun 18.
8
Overexpression of heparanase in mice promoted megakaryopoiesis.在小鼠中过表达乙酰肝素酶可促进巨核细胞生成。
Glycobiology. 2018 May 1;28(5):269-275. doi: 10.1093/glycob/cwy011.
9
Endothelial cell heparanase taken up by cardiomyocytes regulates lipoprotein lipase transfer to the coronary lumen after diabetes.心肌细胞摄取的内皮细胞乙酰肝素酶调节糖尿病后脂蛋白脂肪酶向冠脉管腔的转移。
Diabetes. 2014 Aug;63(8):2643-55. doi: 10.2337/db13-1842. Epub 2014 Mar 7.
10
The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.衔接蛋白 PID1 调节餐后富含甘油三酯的脂蛋白的受体依赖性内吞作用。
Mol Metab. 2018 Oct;16:88-99. doi: 10.1016/j.molmet.2018.07.010. Epub 2018 Jul 30.

引用本文的文献

1
Heparan sulfate chains in hepatocellular carcinoma.肝细胞癌中的硫酸乙酰肝素链
Gastroenterol Rep (Oxf). 2025 Mar 14;13:goaf023. doi: 10.1093/gastro/goaf023. eCollection 2025.
2
Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.肝素酶:治疗动脉粥样硬化的新治疗靶点。
Cells. 2022 Oct 12;11(20):3198. doi: 10.3390/cells11203198.
3
Blood transcriptomic biomarkers of alcohol consumption and cardiovascular disease risk factors: the Framingham Heart Study.饮酒与心血管疾病危险因素的血液转录组生物标志物:弗雷明汉心脏研究。

本文引用的文献

1
Recent insights into factors affecting remnant lipoprotein uptake.近期对影响残余脂蛋白摄取因素的深入了解。
Curr Opin Lipidol. 2010 Jun;21(3):218-28. doi: 10.1097/MOL.0b013e328338cabc.
2
Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.在GPIHBP1缺陷情况下出现的伴有低肝素后脂蛋白脂肪酶水平的乳糜微粒血症。
Circ Cardiovasc Genet. 2010 Apr;3(2):169-78. doi: 10.1161/CIRCGENETICS.109.908905. Epub 2010 Feb 2.
3
Chylomicronemia elicits atherosclerosis in mice--brief report.乳糜微粒血症引发小鼠动脉粥样硬化——简短报告。
Hum Mol Genet. 2023 Jan 27;32(4):649-658. doi: 10.1093/hmg/ddac237.
4
Heparanase Inhibition Prevents Liver Steatosis in E Mice.乙酰肝素酶抑制可预防E小鼠的肝脂肪变性。
J Clin Med. 2022 Mar 17;11(6):1672. doi: 10.3390/jcm11061672.
5
Algal Polysaccharides as Therapeutic Agents for Atherosclerosis.藻类多糖作为动脉粥样硬化的治疗药物
Front Cardiovasc Med. 2018 Oct 26;5:153. doi: 10.3389/fcvm.2018.00153. eCollection 2018.
6
Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.宿主酶乙酰肝素酶和组织蛋白酶 L 促进单纯疱疹病毒 2 从细胞中释放。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01179-18. Print 2018 Dec 1.
7
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.硫酸乙酰肝素蛋白聚糖与高脂血症和动脉粥样硬化的关联。
Matrix Biol. 2018 Oct;71-72:262-282. doi: 10.1016/j.matbio.2018.05.010. Epub 2018 May 24.
8
Diet-induced hypercholesterolemia alters liver glycosaminoglycans and associated-lipoprotein receptors in rats.饮食诱导的高胆固醇血症改变大鼠肝脏糖胺聚糖和相关脂蛋白受体。
J Physiol Biochem. 2017 Nov;73(4):539-550. doi: 10.1007/s13105-017-0583-z. Epub 2017 Jul 31.
9
Heparanase: From basic research to therapeutic applications in cancer and inflammation.乙酰肝素酶:从基础研究到癌症与炎症治疗应用
Drug Resist Updat. 2016 Nov;29:54-75. doi: 10.1016/j.drup.2016.10.001. Epub 2016 Oct 6.
10
Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.硫酸乙酰肝素延长基因EXT1和EXT2功能丧失可改善一氧化氮生物利用度和内皮功能。
J Am Heart Assoc. 2014 Dec 2;3(6):e001274. doi: 10.1161/JAHA.114.001274.
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):20-3. doi: 10.1161/ATVBAHA.109.196329. Epub 2009 Oct 8.
4
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.Syndecan-1是介导小鼠肝脏清除富含甘油三酯脂蛋白的主要硫酸乙酰肝素蛋白聚糖。
J Clin Invest. 2009 Nov;119(11):3236-45. doi: 10.1172/JCI38251. Epub 2009 Oct 1.
5
PI-88: a novel inhibitor of angiogenesis.PI - 88:一种新型血管生成抑制剂。
Expert Opin Investig Drugs. 2008 Nov;17(11):1769-76. doi: 10.1517/13543784.17.11.1769.
6
Molecular processes that handle -- and mishandle -- dietary lipids.处理——以及错误处理——膳食脂质的分子过程。
J Clin Invest. 2008 Oct;118(10):3247-59. doi: 10.1172/JCI35206.
7
Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.具有颈动脉无回声斑块的受试者餐后富含甘油三酯脂蛋白的代谢延迟。
Lipids. 2008 Apr;43(4):353-60. doi: 10.1007/s11745-008-3159-4. Epub 2008 Mar 5.
8
Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.正常饮食下患有严重高甘油三酯血症的老年脂蛋白脂肪酶缺陷小鼠的自发性动脉粥样硬化。
Circ Res. 2008 Feb 1;102(2):250-6. doi: 10.1161/CIRCRESAHA.107.156554. Epub 2007 Nov 21.
9
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.动脉粥样硬化起始过程中的内皮下脂蛋白潴留:最新进展及治疗意义
Circulation. 2007 Oct 16;116(16):1832-44. doi: 10.1161/CIRCULATIONAHA.106.676890.
10
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.乙酰肝素酶:结构、生物学功能以及硫酸乙酰肝素的肝素衍生模拟物对其的抑制作用
Curr Pharm Des. 2007;13(20):2057-73. doi: 10.2174/138161207781039742.